Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Nature Neuroscience|February 19, 2021
Brain capillary pericytes exert a substantial but slow influence on blood flowDavid A Hartmann, Andrée-Anne Berthiaume, Roger I Grant, et al.
Anticancer Research|May 30, 2008
Up-regulation of EphB and ephrin-B expression in rhabdomyosarcomaAnna C Berardi, Sonia Marsilio, Cristina Rofani, et al.
Cell Death & Disease|March 8, 2014
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumorsV Veschi, M Petroni, A Bartolazzi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 21, 2022
Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma-A Randomized, Placebo-Controlled Crossover Trial (MAPLE)Freda Yang, John Busby, Liam G Heaney, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Dose, dose rate and split dose impacts murine skin responses following photon FLASH irradiationKathryn H Brown, Mihaela Ghita-Pettigrew, Malachy P McIvor, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 29, 2009
MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasivenessCristina Evangelisti, Maria Carolina Florian, Isabella Massimi, et al.
Molecular Cancer Research : MCR|December 22, 2010
MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage responseMarialaura Petroni, Veronica Veschi, Andrea Prodosmo, et al.
Oncology Reports|June 7, 2017
A sketch of known and novel MYCN-associated miRNA networks in neuroblastomaFrancesca Megiorni, Moreno Colaiacovo, Samantha Cialfi, et al.
Cancer Letters|March 27, 2017
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cellsFrancesco Marampon, Francesca Megiorni, Simona Camero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcomaFrancesca Diomedi-Camassei, Heather P McDowell, Maria A De Ioris, et al.
Pageof 11